Clinical Trial Update: Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial [Phase 3]

View source ↗

Summary

Phase 3 trial update on adjuvant anal imiquimod therapy for anal HPV lesions (AdAM-trial) is reported; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anogenital Human Papillomavirus Infection
• Condyloma Anal

Drugs mentioned

• Imiquimod (imiquimod)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Anogenital Human Papillomavirus Infection, Condyloma Anal | Phase 3 | Status: UNKNOWN